|
Oct 11
|
Stocks Beating the S&P 500 in 2024 (Excluding NVIDIA)
|
|
Oct 11
|
KeyBioscience and Eli Lilly extend partnership for obesity treatments
|
|
Oct 11
|
Copycat weight loss drugs, Amazon's pharmacies, and CVS vs. Lina Khan: Pharma news roundup
|
|
Oct 11
|
Warning: This Skyrocketing Stock Has a Hidden Risk
|
|
Oct 10
|
Here's Why Eli Lilly (LLY) Fell More Than Broader Market
|
|
Oct 10
|
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
|
|
Oct 10
|
Lilly and insitro team up to develop AI-powered siRNA metabolic drugs
|
|
Oct 10
|
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
|
|
Oct 10
|
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
|
|
Oct 10
|
RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease
|
|
Oct 10
|
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
|
|
Oct 10
|
Market Chatter: Eli Lilly Issues Cease-and-desist Letters to Copycat Weight-loss Drug Makers
|
|
Oct 10
|
2 No-Brainer Dividend Growth Stocks to Buy Right Now
|
|
Oct 10
|
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
|
|
Oct 9
|
LLY, NVS, or ISRG: Which Healthcare Stock Scores Wall Street’s “Strong Buy” Rating?
|
|
Jul 29
|
Wall Street is still jittery on GLP-1s
|
|
Jul 29
|
Alzheimer’s Disease: Some trials to watch over the next year
|
|
Jul 29
|
What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?
|
|
Jul 29
|
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
|
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|